These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16372300)

  • 1. Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.
    Descamps D; Delaugerre C; Masquelier B; Ruffault A; Marcelin AG; Izopet J; Chaix ML; Calvez V; Brun-Vézinet F; Costagliola D
    J Med Virol; 2006 Feb; 78(2):153-60. PubMed ID: 16372300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.
    Fujisaki S; Fujisaki S; Ibe S; Asagi T; Itoh T; Yoshida S; Koike T; Oie M; Konda M; Sadamasu K; Nagashima M; Gatanaga H; Matsuda M; Ueda M; Masakane A; Hata M; Mizogami Y; Mori H; Minami R; Okada K; Watanabe K; Shirasaka T; Oka S; Sugiura W; Kaneda T
    Jpn J Infect Dis; 2007 May; 60(2-3):113-7. PubMed ID: 17515643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.
    Verhofstede C; Van Wanzeele F; Van Der Gucht B; Pelgrom J; Vandekerckhove L; Plum J; Vogelaers D
    J Med Virol; 2007 Sep; 79(9):1254-60. PubMed ID: 17607772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
    Ziemniak C; George-Agwu A; Moss WJ; Ray SC; Persaud D
    J Virol Methods; 2006 Sep; 136(1-2):238-47. PubMed ID: 16828172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
    Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
    J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme.
    Pandit A; Mackay WG; Steel C; van Loon AM; Schuurman R
    J Clin Virol; 2008 Dec; 43(4):401-6. PubMed ID: 18977690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters.
    Corvasce S; Violin M; Romano L; Razzolini F; Vicenti I; Galli A; Duca P; Caramma I; Balotta C; Zazzi M
    Antivir Ther; 2006; 11(3):329-34. PubMed ID: 16759049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
    Paraschiv S; Otelea D; Baicus C; Tinischi M; Costache M; Neaga E
    Int J Infect Dis; 2009 Jan; 13(1):81-9. PubMed ID: 18632295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.
    Bon I; Gibellini D; Borderi M; Alessandrini F; Vitone F; Schiavone P; Re MC
    J Clin Virol; 2007 Apr; 38(4):313-20. PubMed ID: 17306618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update of the drug resistance mutations in HIV-1: Fall 2006.
    Johnson VA; Brun-Vezinet F; Clotet B; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD
    Top HIV Med; 2006; 14(3):125-30. PubMed ID: 16946457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 drug resistance surveillance using dried whole blood spots.
    Bertagnolio S; Soto-Ramirez L; Pilon R; Rodriguez R; Viveros M; Fuentes L; Harrigan PR; Mo T; Sutherland D; Sandstrom P
    Antivir Ther; 2007; 12(1):107-13. PubMed ID: 17503754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
    Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Background study of HIV-1 drug resistant mutations in treatment-naive patients in liaoning province].
    Han XX; Zhang M; Dai D; Lu C; Zhang ZN; Liu J; Wang YN; Jiang YJ; Shang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):632-6. PubMed ID: 17121220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.